Major new brand campaign developed with Colin Jost’s No Notes Productions lampoons bad tech and champions the employees who suffer for it SAN JOSE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE)
Slovenia highlights 2026 LJUBLJANA, Slovenia, Dec. 10, 2025 (GLOBE NEWSWIRE) — In 2026, Slovenia invites travelers – and storytellers – to explore a year rich in cultural milestones, outdoor adventures
Built on Maestro by Equativ, this is the first of a full suite of Equativ AI Agents for buyers that simplifies media planning, drives smarter decisions, higher ROAS, and scalable
Bitget Reports Record 4,468% Surge in Tokenized US Stock Futures During Earnings Season VICTORIA, Seychelles, Dec. 09, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has released
RICHARDSON, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mavenir, the software company building AI-by-design mobile networks, today announced a strong leadership team to accelerate its vision for telco-first, cloud-native, AI-by-design
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)
Major new brand campaign developed with Colin Jost’s No Notes Productions lampoons bad tech and champions the employees who suffer for it SAN JOSE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE)
Slovenia highlights 2026 LJUBLJANA, Slovenia, Dec. 10, 2025 (GLOBE NEWSWIRE) — In 2026, Slovenia invites travelers – and storytellers – to explore a year rich in cultural milestones, outdoor adventures
Built on Maestro by Equativ, this is the first of a full suite of Equativ AI Agents for buyers that simplifies media planning, drives smarter decisions, higher ROAS, and scalable
Bitget Reports Record 4,468% Surge in Tokenized US Stock Futures During Earnings Season VICTORIA, Seychelles, Dec. 09, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has released
RICHARDSON, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mavenir, the software company building AI-by-design mobile networks, today announced a strong leadership team to accelerate its vision for telco-first, cloud-native, AI-by-design
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)
